Equities

Futura Medical PLC

Futura Medical PLC

Actions
  • Price (EUR)0.408
  • Today's Change0.004 / 0.99%
  • Shares traded0.00
  • 1 Year change-6.42%
  • Beta--
Data delayed at least 15 minutes, as of Aug 05 2022 07:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Futura Medical plc is a United Kingdom-based pharmaceutical company. The Company is focused on developing a portfolio of products based on its transdermal DermaSys technology. Its patented transdermal DermaSys technology provides rapid and targeted local delivery of medical treatments via the skin. The Company is engaged in developing a portfolio of products for therapeutic areas, such as sexual health, including erectile dysfunction, and pain relief. The Company's products include MED3000 and TPR100. The Company's lead product, MED3000, is a topical gel formulation treatment for erectile dysfunction (ED) through an evaporative mode of action. The Company has conducted a Phase III study using MED3000 in ED. TPR100 is a topical non-steroidal anti-inflammatory for the pain and inflammation associated with sprains, strains and bruises and soft tissue rheumatism.

  • Revenue in GBP (TTM)0.00
  • Net income in GBP-4.96m
  • Incorporated2001
  • Employees11.00
  • Location
    Futura Medical PLCUnit 40Surrey Technology Centre, Occam RoadGUILDFORD GU2 7YGUnited KingdomGBR
  • Phone+44 148 368 5670
  • Fax+44 148 368 5671
  • Websitehttp://www.futuramedical.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.